Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Ruoheng Zheng, Chuanping Lin, Yuchan Mao & Fan Jin. (2023) miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis. Gynecological Endocrinology 39:1.
Read now
Read now
Yan Li, Nianling Yao, Yan Gao, Yunping Wang, Lu Bai, Jia Xu & Haixu Wang. (2021) MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1. Bioengineered 12:1, pages 8555-8569.
Read now
Read now
Zhaowei Cai, Shaojuan He, Tao Li, Li Zhao & Kerong Zhang. (2020) Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K/Akt/mTOR pathway. Animal Cells and Systems 24:4, pages 197-204.
Read now
Read now
Antonio Mancini, Alessandro Brunetti, Carmine Bruno, Edoardo Vergani, Krizia Pocino, Cecilia Napodano, Francesca Gulli, Stefano Angelo Santini & Umberto Basile. (2019) Plasmatic free light chains in polycystic ovary syndrome. Gynecological Endocrinology 35:8, pages 710-713.
Read now
Read now
Vahid Maleki, Hamed Jafari-Vayghan, Arvin Kashani, Fardin Moradi, Mahdi Vajdi, Sorayya Kheirouri & Mohammad Alizadeh. (2019) Potential roles of carnitine in patients with polycystic ovary syndrome: a systematic review. Gynecological Endocrinology 35:6, pages 463-469.
Read now
Read now
Eric Nilsson, Rachel Klukovich, Ingrid Sadler-Riggleman, Daniel Beck, Yeming Xie, Wei Yan & Michael K. Skinner. (2018) Environmental toxicant induced epigenetic transgenerational inheritance of ovarian pathology and granulosa cell epigenome and transcriptome alterations: ancestral origins of polycystic ovarian syndrome and primary ovarian insufficiency. Epigenetics 13:8, pages 875-895.
Read now
Read now
Cihan Karadağ, Tevfik Yoldemir & Dilek Gogas Yavuz. (2017) Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients. Gynecological Endocrinology 33:3, pages 234-237.
Read now
Read now
Larry Brooks, Joseph Hadi, Kyle T Amber, Michelle Weiner, Christopher L La Riche & Tamar Ference. (2015) Assessing the prevalence of autoimmune, endocrine, gynecologic, and psychiatric comorbidities in an ethnically diverse cohort of female fibromyalgia patients: does the time from hysterectomy provide a clue?. Journal of Pain Research 8, pages 561-569.
Read now
Read now
Cai-Fei Ding, Wang-Qiang Chen, Yu-Tian Zhu, Ya-Li Bo, Hui-Min Hu & Ruo-Heng Zheng. (2015) Circulating microRNAs in patients with polycystic ovary syndrome. Human Fertility 18:1, pages 22-29.
Read now
Read now
Dorte Glintborg, Anne Pernille Hermann & Marianne Andersen. (2013) Bone mineral density and vitamin D in PCOS and hirsutism. Expert Review of Endocrinology & Metabolism 8:5, pages 449-459.
Read now
Read now
Krystle Ebejer & Jean Calleja-Agius. (2013) The role of cytokines in polycystic ovarian syndrome. Gynecological Endocrinology 29:6, pages 536-540.
Read now
Read now
Ibrahim Alanbay, Cihangir Mutlu Ercan, Hakan Coksuer, Mehmet Sakinci, Kazim Emre Karasahin, Ozlem Ozturk & Halil Yaman. (2012) Neopterin: a promising marker for the inflammation in polycystic ovary syndrome. Gynecological Endocrinology 28:11, pages 879-883.
Read now
Read now
Carmen Emanuela Pepene. (2012) Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction. Gynecological Endocrinology 28:5, pages 370-374.
Read now
Read now
Ji Won Kim, Ji Eun Han, You Shin Kim, Hyung Jae Won, Tae Ki Yoon & Woo Sik Lee. (2012) High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome. Gynecological Endocrinology 28:4, pages 259-263.
Read now
Read now
Dorte Glintborg, Hanne Mumm, David M. Hougaard, Pernille Ravn & Marianne Andersen. (2012) Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome. Gynecological Endocrinology 28:3, pages 170-174.
Read now
Read now
A. C. Herlihy, R. E. Kelly, J. L. Hogan, N. O'Connor, N. Farah & M. J. Turner. (2011) Polycystic ovary syndrome and the peripheral blood white cell count. Journal of Obstetrics and Gynaecology 31:3, pages 242-244.
Read now
Read now
Dorte Glintborg & Marianne Andersen. (2010) Thiazolinedione treatment in PCOS – an update. Gynecological Endocrinology 26:11, pages 791-803.
Read now
Read now
Magdalene Andries, Dorte Glintborg & Marianne Andersen. (2010) Risk of impaired glucose tolerance in normal weight hirsute women during four years observation. Acta Obstetricia et Gynecologica Scandinavica 89:8, pages 1091-1095.
Read now
Read now
Articles from other publishers (90)
Aastha Sharma, Keshav Bansal & Meenakshi Bajpai. (2024) The Role of Different Medicinal Herbs in Treatment of Polycystic Ovary
Syndrome: A Review. The Natural Products Journal 14:1.
Crossref
Crossref
Samira Eivazi, Asma Kheirollahi, Akram Vatannejad, Nasrin Borumandnia, Behnam Habibi, Somayeh Shapourizadeh, Fatima Zahraa Fouani, Soheila Ansaripour, Sadegh Eivazi & Zahra Zandieh. (2023) The hormone-sensitive lipase C-60G polymorphism is correlated with recurrent spontaneous abortion in women with polycystic ovary syndrome. Gene Reports 32, pages 101788.
Crossref
Crossref
Yahui Zhang, Yi Lin, Guoqiang Li, Yuan Yuan, Xuejiao Wang, Na Li, Chuanhao Xiong, Yueying Yang, Yuhang Ma, Zhijian Zhang & Xiaoying Ding. (2023) Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue. Biology of Reproduction 108:6, pages 945-959.
Crossref
Crossref
Yan Sun, Shouyang Gao, Cong Ye & Weiliang Zhao. (2023) Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Ying Wang, Jiyu Yang, Yu Wang, Yao Chen, Yiran Wang, Hongying Kuang & Xiaoling Feng. (2023) Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome. Molecular and Cellular Endocrinology 561, pages 111824.
Crossref
Crossref
M.M. Sonova, L.K. Barsegian & J.P. Nurullina. (2023) Obesity in routine practice, a gynecologist’s view of a multidisciplinary problem. Problemy reproduktsii 29:4, pages 81.
Crossref
Crossref
Md. Arju Hossain, Sheikh Abdullah Al Ashik, Moshiur Rahman Mahin, Md. Al Amin, Md Habibur Rahman, Md. Arif Khan & Abdullah Al Emran. (2022) Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders. Heliyon 8:12, pages e12480.
Crossref
Crossref
Dorte Glintborg, Tanja Gram Petersen, Katrine Hass Rubin & Marianne Skovsager Andersen. (2022) Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome—A National Cohort Study. Biomedicines 10:10, pages 2396.
Crossref
Crossref
Fazilah Abdul Hamid, Muhammad Azrai Abu, Abdul Kadir Abdul Karim, Mohd Faizal Ahmad, Nor Haslinda Abd. Aziz, Datu Agasi Mohd Kamal & Mohd Helmy Mokhtar. (2022) Sex Steroid Receptors in Polycystic Ovary Syndrome and Endometriosis: Insights from Laboratory Studies to Clinical Trials. Biomedicines 10:7, pages 1705.
Crossref
Crossref
Vikrant Ghatnatti, Shwetha Patil & Harpreet Kour. (2022) Assessment of clinical, biochemical, and hormonal profile of lean versus overweight polycystic ovarian syndrome patients: A cross-sectional study. APIK Journal of Internal Medicine 10:1, pages 13.
Crossref
Crossref
P.M. Spritzer, B.R. Santos, T.M. Fighera, L.B. Marchesan & S.B. Lecke. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
73
96
.
Debasmita Ghosh Roy & P. A. Alvi. 2022. Contemporary Issues in Communication, Cloud and Big Data Analytics. Contemporary Issues in Communication, Cloud and Big Data Analytics
453
463
.
Stefan Kluzek, Katrine Hass Rubin, Maria Sanchez-Santos, Mary S. O’Hanlon, Marianne Andersen, Dorte Glintborg & Bo Abrahamsen. (2021) Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Wanqin Feng, Yan Zhang, Yuan Pan, Yi Zhang, Minjuan Liu, Yuxin Huang, Yuanling Xiao, Wenyu Mo, Junjie Jiao, Xiaoyang Wang, Dan Tian, Lixia Yang & Ying Ma. (2021) Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women. Reproductive Biology and Endocrinology 19:1.
Crossref
Crossref
AANCHHAL, RAHUL MEHRA, AMIT BARWAL & SURYA PARKASH GAUTAM. (2021) IMPORTANCE OF HAIR GROWTH IN HISUTISM: DIAGNOSIS AND TREATMENT. International Journal of Current Pharmaceutical Research, pages 43-49.
Crossref
Crossref
Sabira Sultana, Naheed Akhter, Muhammad Akram, Syed Muhammad Ali Shah, Naveed Munir, Muhammad Riaz, Aziz-ur-Rehman, Samina Perveen & Tayyaba Ashraf. 2021. Alternative Medicine - Update. Alternative Medicine - Update.
Zora Lazúrová, Jana Figurová, Beáta Hubková, Jana Mašlanková & Ivica Lazúrová. (2021) Urinary bisphenol A in women with polycystic ovary syndrome – a possible suppressive effect on steroidogenesis?. Hormone Molecular Biology and Clinical Investigation 42:3, pages 303-309.
Crossref
Crossref
Xiaoyu Long, Honghao Wang, Xiaohui Zhu, Rong Li, Yan Yang & Jie Qiao. (2021) C/EBP-β and SIRT1 regulate IL-18 expression in the proliferative phase endometria of polycystic ovary syndrome patients. Gynecology and Obstetrics Clinical Medicine 1:2, pages 94-99.
Crossref
Crossref
Su Liu, Ling Hong, Meilan Mo, Shan Xiao, Cong Chen, Yuye Li, Ruochun Lian, Xuejin Wang, Songchen Cai, Lianghui Diao & Yong Zeng. (2021) Evaluation of endometrial immune status of polycystic ovary syndrome. Journal of Reproductive Immunology 144, pages 103282.
Crossref
Crossref
M. Amiri, M. Rahmati, M. Hedayati, F. Nahidi & F. Ramezani Tehrani. (2020) Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial. Journal of Endocrinological Investigation 44:3, pages 567-580.
Crossref
Crossref
Haiyan Yang, Jie Lin, He Li, Zhangwei Liu, Xia Chen & Qianqian Chen. (2021) Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology 12.
Crossref
Crossref
Swastika PurohitSeema RaiShubhada Kalvit. (2021) Prevalence of polycystic ovarian syndrome and its association with circulatory gonadotropins (luteinizing hormone and follicle-stimulating hormone) and prolactin in different reproductive age groups: A brief survey. Journal of Reproductive Healthcare and Medicine 2, pages 8.
Crossref
Crossref
Nikhita Chahal, Molly Quinn, Eleni A. Jaswa, Chia-Ning Kao, Marcelle I. Cedars & Heather G. Huddleston. (2020) Comparison of metabolic syndrome elements in White and Asian women with polycystic ovary syndrome: results of a regional, American cross-sectional study. F&S Reports 1:3, pages 305-313.
Crossref
Crossref
Stephanie Pirotta, Anju Joham, Jessica A. Grieger, Chau Tien Tay, Mahnaz Bahri-Khomami, Marla Lujan, Siew S. Lim & Lisa J. Moran. (2021) Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome. Seminars in Reproductive Medicine 38:06, pages 342-351.
Crossref
Crossref
Erifili Hatziagelaki, Vasilios Pergialiotis, Julia M. Kannenberg, Eftihios Trakakis, Anastasia Tsiavou, Daniel F. Markgraf, Maren Carstensen-Kirberg, Giovanni Pacini, Michael Roden, George Dimitriadis & Christian Herder. (2019) Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome. Experimental and Clinical Endocrinology & Diabetes 128:11, pages 723-730.
Crossref
Crossref
A B Schmidt, M Lund, J Wohlfahrt & M Melbye. (2020) Polycystic ovary syndrome and offspring risk of congenital heart defects: a nationwide cohort study. Human Reproduction 35:10, pages 2348-2355.
Crossref
Crossref
Yifang Wei, Shenglian Lu, Yu Hu, Li Guo, Xiaoyu Wu, Xing Liu & Yun Sun. (2020) MicroRNA-135a Regulates VEGFC Expression and Promotes Luteinized Granulosa Cell Apoptosis in Polycystic Ovary Syndrome. Reproductive Sciences 27:7, pages 1436-1442.
Crossref
Crossref
Haiyan Yang, Junbo Di, Jiexue Pan, Rong Yu, Yili Teng, Zhuhua Cai & Xiaohui Deng. (2020) The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis. Frontiers in Endocrinology 11.
Crossref
Crossref
Indre Petraitiene, Margarita Valuniene, Kristina Jariene, Audrone Seibokaite, Kerstin Albertsson-Wikland & Rasa Verkauskiene. (2020) Sex Hormones, Gonad Size, and Metabolic Profile in Adolescent Girls Born Small for Gestational Age with Catch-up Growth. Journal of Pediatric and Adolescent Gynecology 33:2, pages 125-132.
Crossref
Crossref
Zeng-Hong Wu, Yun Tang, Xun Niu, Fei-Fei Pu, Xi-Yue Xiao & Wen Kong. (2019) Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis. Journal of Ovarian Research 12:1.
Crossref
Crossref
D Vassard, L Schmidt, C H Glazer, J Lyng Forman, M Kamper-Jørgensen & A Pinborg. (2019) Assisted reproductive technology treatment and risk of ovarian cancer—a nationwide population-based cohort study. Human Reproduction 34:11, pages 2290-2296.
Crossref
Crossref
Do Kyeong Song, Hyejin Lee, Young Sun Hong & Yeon-Ah Sung. (2019) Insulin resistance is associated with hirsutism in unselected reproductive-aged women. Clinical Endocrinology 90:4, pages 586-591.
Crossref
Crossref
Katrine H. Rubin, Marianne S. Andersen, Bo Abrahamsen & Dorte Glintborg. (2019) Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study. Acta Obstetricia et Gynecologica Scandinavica 98:4, pages 440-450.
Crossref
Crossref
Juan Li, Li-Min Xie, Jin-Long Song, Lee-Fong Yau, Jia-Ning Mi, Chun-Ren Zhang, Wan-Ting Wu, Mao-Hua Lai, Zhi-Hong Jiang, Jing-Rong Wang & Hong-Xia Ma. (2019) Alterations of Sphingolipid Metabolism in Different Types of Polycystic Ovary Syndrome. Scientific Reports 9:1.
Crossref
Crossref
Xuemei Fan, Jianfa Jiang, Zhiqiang Huang, Jumei Gong, Yiming Wang, Wei Xue, Yan Deng, Yanfang Wang, Tingping Zheng, Aijun Sun & Guoan Luo. (2018) UPLC/Q‑TOF‑MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome. Molecular Medicine Reports.
Crossref
Crossref
Hsin-Yi Yang, Herng-Sheng Lee, Wan-Ting Huang, Ming-Jer Chen, Solomon Chih-Cheng Chen & Yueh-Han Hsu. (2017) Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study. Journal of Bone and Mineral Metabolism 36:6, pages 741-748.
Crossref
Crossref
Andon Hestiantoro, Rachmat Dediat Kapnosa Hasani, Amalia Shadrina, Herbert Situmorang, Nurul Ilma, Raden Muharam, Kanadi Sumapraja & Budi Wiweko. (2018) Body fat percentage is a better marker than body mass index for determining inflammation status in polycystic ovary syndrome. International Journal of Reproductive BioMedicine 16:10, pages 623-628.
Crossref
Crossref
Noura Mohammed Al Bassam, Sarah Ali & Syed Raziur Rahman. (2018) POLYCYSTIC OVARIAN SYNDROME(PCOS), AWARENESS AMONG FEMALE STUDENTS, QASSIM UNIVERSITY, QASSIM REGION, SAUDI ARABIA. International Journal of Research -GRANTHAALAYAH 6:9, pages 395-406.
Crossref
Crossref
Andreas J. T. Pedersen, Tore Bjerregaard Stage, Dorte Glintborg, Marianne Andersen & Mette Marie Hougaard Christensen. (2017) The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial. Basic & Clinical Pharmacology & Toxicology 122:2, pages 239-244.
Crossref
Crossref
Sam Lepine, Junyoung Jo, Mostafa Metwally & Ying C Cheong. (2017) Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2017:11.
Crossref
Crossref
Haoran Shen, Zhou Liang, Saihua Zheng & Xuelian Li. (2017) Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome. International Journal of Molecular Medicine 40:5, pages 1385-1396.
Crossref
Crossref
Dorte Glintborg & Marianne Andersen. (2017) MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome. European Journal of Endocrinology 176:2, pages R53-R65.
Crossref
Crossref
Xiaoyu Long, Rong Li, Yan Yang & Jie Qiao. (2017) Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome. Reproductive Sciences 24:2, pages 252-257.
Crossref
Crossref
Suna Kabil Kucur, Ali Seven, Beril Yuksel, Cuneyt Kucur, Halime Sencan, Ilay Gozukara & Nadi Keskin. (2016) Alterations in nasal mucociliary activity in polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 207, pages 169-172.
Crossref
Crossref
Dorte Glintborg, Maria Houborg Petersen, Pernille Ravn, Anne Pernille Hermann & Marianne Andersen. (2016) Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Acta Obstetricia et Gynecologica Scandinavica 95:11, pages 1235-1243.
Crossref
Crossref
Hanne Mumm, Magda Lambaa Altinok, Jan Erik Henriksen, Pernille Ravn, Dorte Glintborg & Marianne Andersen. (2016) Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome. Human Reproduction 31:5, pages 1105-1112.
Crossref
Crossref
Katrine Hass Rubin, Dorte Glintborg, Mads Nybo, Marianne Andersen & Bo Abrahamsen. (2015) Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register‐Based and Population‐Based Cohort Study. Journal of Bone and Mineral Research 31:4, pages 709-717.
Crossref
Crossref
Kirsten Kaya Roessler. 2016. Sport and Exercise Psychology Research. Sport and Exercise Psychology Research
461
485
.
Hongxi Xue, Han Zhao, Xin Liu, Yue-ran Zhao, Zi-Jiang Chen & Jinlong Ma. (2015) Association of single-nucleotide polymorphisms rs2197076 and rs2241883 of FABP1 gene with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics 33:1, pages 75-83.
Crossref
Crossref
Avin S Jamil, Shahla K Alalaf, Namir G Al-Tawil & Talha Al-Shawaf. (2015) A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Reproductive Health 12:1.
Crossref
Crossref
Wen Kong, Xun Niu, Tianshu Zeng, Meixia Lu & Lulu Chen. (2015) Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis. PLOS ONE 10:10, pages e0140565.
Crossref
Crossref
Dorte Glintborg, Johannes J. Sidelmann, Magda Lambaa Altinok, Hanne Mumm & Marianne Andersen. (2015) Increased thrombin generation in women with polycystic ovary syndrome. Metabolism 64:10, pages 1272-1278.
Crossref
Crossref
Ying-Ying Yu, Cui-Xiang Sun, Yin-Kun Liu, Yan Li, Li Wang & Wei Zhang. (2015) Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome. Fertility and Sterility 104:1, pages 145-153.e6.
Crossref
Crossref
Lingxia Ha, Yuhua Shi, Junli Zhao, Tao Li & Zi-Jiang Chen. (2015) Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women. PLOS ONE 10:5, pages e0126505.
Crossref
Crossref
Poli Mara Spritzer, Sheila B Lecke, Fabíola Satler & Debora M Morsch. (2015) Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. REPRODUCTION 149:5, pages R219-R227.
Crossref
Crossref
Leyla Akın, Mustafa Kendirci, Figen Narin, Selim Kurtoglu, Recep Saraymen, Meda Kondolot, Selda Koçak & Ferhan Elmalı. (2015) The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls. Acta Paediatrica 104:4, pages e171-e177.
Crossref
Crossref
D. Glintborg, M. L. Altinok, K. R. Petersen & P. Ravn. (2015) Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours. Case Reports 2015:jan23 1, pages bcr2014204797-bcr2014204797.
Crossref
Crossref
D. Glintborg, M. Altinok, H. Mumm, K. Buch, P. Ravn & M. Andersen. (2014) Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome. Human Reproduction 29:8, pages 1773-1779.
Crossref
Crossref
Dorte Glintborg, Hanne Mumm, Magda Lambaa Altinok, Bjørn Richelsen, Jens Meldgaard Bruun & Marianne Andersen. (2014) Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome. Journal of Endocrinological Investigation 37:8, pages 757-764.
Crossref
Crossref
Dorte Glintborg, Magda Lambaa Altinok, Hanne Mumm, Anne Pernille Hermann, Pernille Ravn & Marianne Andersen. (2014) Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 99:7, pages 2584-2591.
Crossref
Crossref
M. L. Altinok, D. Glintborg, R. dePont Christensen, J. Hallas & M. Andersen. (2014) Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study. Clinical Endocrinology 80:6, pages 884-889.
Crossref
Crossref
Mette B. Eriksen, Michael F. B. Nielsen, Klaus Brusgaard, Qihua Tan, Marianne S. Andersen, Dorte Glintborg & Michael Gaster. (2013) Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS). PLoS ONE 8:9, pages e77186.
Crossref
Crossref
Lan Li, Kyung-Ju Lee, Bum-Chae Choi & Kwang-Hyun Baek. (2013) Relationship between leptin receptor and polycystic ovary syndrome. Gene 527:1, pages 71-74.
Crossref
Crossref
Q. Cheng, W. Xia, S. Yang, P. Ye, M. Mei, Y. Song, M. Luo & Q. Li. (2014) Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome. Journal of Endocrinological Investigation 36:8, pages 632-635.
Crossref
Crossref
Kirsten K. Roessler, Dorte Glintborg, Pernille Ravn, Camilla Birkebaek & Marianne Andersen. (2013) Supportive relationships – Psychological effects of group counselling in women with polycystic ovary syndrome (PCOS). Communication and Medicine 9:2, pages 125-131.
Crossref
Crossref
C. Celik, R. Abali, E. Bastu, N. Tasdemir, U. G. Tasdemir & A. Gul. (2013) Assessment of impaired glucose tolerance prevalence with hemoglobin A1c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study. Human Reproduction 28:4, pages 1062-1068.
Crossref
Crossref
Kirsten K. Roessler, Camilla Birkebaek, Pernille Ravn, Marianne S. Andersen & Dorte Glintborg. (2013)
Effects of exercise and group counselling on body composition and
VO
2max
in overweight women with polycystic ovary syndrome
. Acta Obstetricia et Gynecologica Scandinavica 92:3, pages 272-277.
Crossref
Crossref
Hanne Mumm, Mads Kamper-Jørgensen, Anne-Marie Nybo Andersen, Dorte Glintborg & Marianne Andersen. (2013) Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973–1991. Fertility and Sterility 99:3, pages 777-782.
Crossref
Crossref
Jane Lyttleton. 2013. Treatment of Infertility with Chinese Medicine. Treatment of Infertility with Chinese Medicine
140
232
.
NINA SOFIE LILLEGAARD HOLM, DORTE GLINTBORG, MARIANNE SKOVSAGER ANDERSEN, DORIS SCHLEDERMANN & PERNILLE RAVN. (2012) The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism. Acta Obstetricia et Gynecologica Scandinavica 91:10, pages 1173-1176.
Crossref
Crossref
M Yamamoto, S L Feigenbaum, Y Crites, G J Escobar, J Yang, A Ferrara & J C Lo. (2012) Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome. Journal of Perinatology 32:10, pages 770-776.
Crossref
Crossref
Joo-Yeon Hwang, Eun-Ju Lee, Min Jin Go, Yeon-Ah Sung, Hye Jin Lee, Soo Heon Kwak, Hak C Jang, Kyung Soo Park, Hye-Ja Lee, Han Byul Jang, Jihyun Song, Kyung-Hee Park, Hyung-Lae Kim, Myeong-Chan Cho & Jong-Young Lee. (2012) Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. Journal of Human Genetics 57:10, pages 660-664.
Crossref
Crossref
Ibrahim Alanbay, Cihangir Mutlu Ercan, Mehmet Sakinci, Hakan Coksuer, Mustafa Ozturk & Serkan Tapan. (2012) A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity?. Archives of Gynecology and Obstetrics 286:4, pages 1065-1071.
Crossref
Crossref
Mette B. Eriksen, Klaus Brusgaard, Marianne Andersen, Qihua Tan, Magda L. Altinok, Michael Gaster & Dorte Glintborg. (2012) Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis. European Journal of Obstetrics & Gynecology and Reproductive Biology 163:1, pages 39-42.
Crossref
Crossref
Eric Nilsson, Ginger Larsen, Mohan Manikkam, Carlos Guerrero-Bosagna, Marina I. Savenkova & Michael K. Skinner. (2012) Environmentally Induced Epigenetic Transgenerational Inheritance of Ovarian Disease. PLoS ONE 7:5, pages e36129.
Crossref
Crossref
Ying C Cheong, Mostafa Metwally, Norman Shreeve, Khaled Sadek & Cindy Farquhar. (2011) Ovarian surgery for symptom relief in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Elizabeth Jedel, Deborah Gustafson, Margda Waern, Yrsa Bergmann Sverrisdottir, Mikael Landén, Per Olof Janson, Fernand Labrie, Claes Ohlsson & Elisabet Stener-Victorin. (2011) Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome. Psychoneuroendocrinology 36:10, pages 1470-1479.
Crossref
Crossref
Line Velling Magnussen, Hanne Mumm, Marianne Andersen & Dorte Glintborg. (2011) Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome. Fertility and Sterility 96:5, pages 1275-1280.
Crossref
Crossref
C. Bunchorntavakul, R. Bahirwani, D. Drazek, M. C. Soulen, E. S. Siegelman, E. E. Furth, K. Olthoff, A. Shaked & K. R. Reddy. (2011) Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Alimentary Pharmacology & Therapeutics 34:6, pages 664-674.
Crossref
Crossref
K.K. Roessler, M. Andersen, D. Glintborg, P. Ravn & C. Birkebaek. (2011) F417 GROUP COUNSELLING AND PHYSICAL ACTIVITY OF PATIENTS WITH POLYCYSTIC OVARIAL SYNDROME (PCOS). European Journal of Pain Supplements 5:S1, pages 156-156.
Crossref
Crossref
X. Wang, R. Chow, L. Deng, D. Anderson, N. Weidner, A. K. Godwin, C. Bewtra, A. Zlotnik, J. Bui, A. Varki & N. Varki. (2011) Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. Glycobiology 21:8, pages 1038-1048.
Crossref
Crossref
MALLIKA AZIZIA & PAUL HARDIMAN. (2011) COMPLICATIONS OF PREGNANCY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME. Fetal and Maternal Medicine Review 22:3, pages 188-206.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Rheumatology 23:4, pages 406-409.
Crossref
Crossref
José Alfredo Martínez-Hernández, Diego Martínez-Urbistondo & Francisco José Carapeto Márquez de Prado. (2011) Manifestaciones cutáneas en la obesidad. Revista Española de Nutrición Humana y Dietética 15:2, pages 56-61.
Crossref
Crossref
Nissi M. VarkiElizabeth Strobert, Edward J. DickJr.Jr., Kurt BenirschkeAjit Varki. (2011) Biomedical Differences Between Human and Nonhuman Hominids: Potential Roles for Uniquely Human Aspects of Sialic Acid Biology. Annual Review of Pathology: Mechanisms of Disease 6:1, pages 365-393.
Crossref
Crossref
Keizo Kanasaki & Daisuke Koya. (2011) Biology of Obesity: Lessons from Animal Models of Obesity. Journal of Biomedicine and Biotechnology 2011, pages 1-11.
Crossref
Crossref
Mette Eriksen, Ann Dorte Pørneki, Vibe Skov, Jorge S. Burns, Henning Beck-Nielsen, Dorte Glintborg & Michael Gaster. (2010) Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS. PLoS ONE 5:12, pages e14469.
Crossref
Crossref
Bee K. TanRaghu AdyaSyed FarhatullahJing ChenHendrik LehnertHarpal S. Randeva. (2010) Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome. Diabetes 59:12, pages 3023-3031.
Crossref
Crossref
Dorte Glintborg, Hanne Mumm, David Hougaard, Pernille Ravn & Marianne Andersen. (2010) Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clinical Endocrinology 73:6, pages 732-738.
Crossref
Crossref
Ian S Young & D Paul Nicholls. (2010) Lipid metabolism. Current Opinion in Lipidology 21:6, pages 550-551.
Crossref
Crossref